Skip to content

Inomax Dsir (Delivery System)

by Ino Therapeutics/Ikaria

510(k) K131686

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

4 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 11 Oct 2026. What this means

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK131686 Date29 Nov 2013ClearedStatusActive

Recalls

4 recalls · FDA

    • Terminated Z-2733-2018 FDA Class II initiated 9 Jul 2018

    INOmeters affixed to the INOflo cylinders in Lot 17FP-0570 were programmed with an incorrect expiration date (11/2017). For Lot 17FP-0570, the label affixed to each INOflo cylinder has the correct expiration date noted (11/2020).

    • Terminated Z-1076-2017 FDA Class II initiated 21 Nov 2016

    Mallinckrodt discovered that some devices may have been manufactured with an out-of-tolerance manometer which can result in in an inaccurate proportional valve calibration table in an affected device.

    • Terminated Z-0575-2015 FDA Class II initiated 17 Oct 2014

    An issue has been identified in the INOmax DSIR system that could result in monitored Nitric Oxide (NO) concentration reporting lower than expected. This issue only pertains to those devices manufactured using a specific version of the Monitoring Circuit Board.

    • Terminated Z-1528-2014 FDA Class II initiated 27 Mar 2014

    An anomaly impacts the monitoring system of INOmax DSIR Plus (software 3.0.0). When the integrated pneumatic backup switch is activated with low or no gas flow through the injector module, an intended NO cell failure alarm will occur. In addition, an unintended NO2 cell failure alarm may also occur. The NO/NO2 cell failure alarms are caused by an average NO/NO2 circuit concentration greater tha

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MRN
Device Class
Class II
Regulation
21 CFR Part 868.5165
Advisory Committee
Anesthesiology
FDA Decision
SESE Substantially Equivalent

Other devices from Ino Therapeutics/Ikaria